SOURCE: Prana Biotechnology

March 13, 2008 08:30 ET

Prana Biotechnology to Present at the Cowen and Company Healthcare Conference

MELBOURNE, AUSTRALIA--(Marketwire - March 13, 2008) - Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, today announced that the Company is scheduled to present at the Cowen and Company Healthcare Conference 2008, March 17-20, 2008, in Boston, MA.

Steven Targum, Chief Medical Advisor of Prana, will give a presentation of the Company discussing the current status and results of Prana's clinical trials. The presentation will begin at 11:30 a.m. on Monday, March 17, followed by a question and answer session. Management will be available for investor meetings throughout the conference.

The Company will also be featured on a conference call on Friday, March 14 at 1.p.m. EDT, coordinated by Rodman & Renshaw, discussing innovative approaches in Alzheimer's disease therapy.

For more information regarding the conference call or Cowen healthcare conference, please visit the Prana website at www.pranabio.com

About Prana Biotechnology Limited

Prana Biotechnology was established to commercialize research into Alzheimer's Disease and other major age-related neurodegenerative disorders. The Company was incorporated in 1997 and listed on the Australian Stock Exchange in March 2000 and listed on NASDAQ in September 2002. Researchers at prominent international institutions including The University of Melbourne, The Mental Health Research Institute (Melbourne) and Massachusetts General Hospital, a teaching hospital of Harvard Medical School, contributed to the discovery of Prana's technology.

For further information, please visit the Company's web site at www.pranabio.com

Contact Information